CRE-ating Success: Optimizing Antibiotic Therapy for Carbapenem-Resistant Enterobacterales Bacteremia

In this educational program, learn from expert faculty about developing individualized treatment plans for patients with carbapenem-resistant Enterobacterales (CRE) bacteremia, including interpretation of rapid diagnostic results, appropriate utilization of CRE-active agents based on IDSA guidance, and dose optimization strategies. Reinforce your learning with the downloadable infographic on antibiotic selection for CRE infections based on detected resistance genes.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from bioMérieux, Inc.

bioMérieux, Inc.